Overview Request Sample Pages Request Customization Download PDF
You are viewing: Japan Blood Collection Devices Market analysis

The Japan Blood Collection Devices Market was valued at $272 Million in 2025 and projected to reach to $428.8 Million by 2030, representing a compound annual growth rate of 9.5%. Japan's blood collection devices market is positioned for sustained growth, expanding from $272.0 million in 2025 to $428.8 million by 2030 at a 9.5% CAGR.

Japan Blood Collection Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Blood Collection Devices Market Trends and Insights

  • This 9.5% compound annual growth rate reflects Japan's aging population, increased diagnostic testing demand, and advanced healthcare infrastructure.
  • Japan's market expansion outpaces the global average of 7.4%, driven by rising prevalence of chronic diseases and enhanced blood screening protocols across hospitals and diagnostic centers. The Japanese market benefits from stringent regulatory standards and high adoption of safety-engineered devices that minimize needlestick injuries.
  • Japan's emphasis on infection control and quality healthcare delivery supports sustained demand for innovative blood collection solutions.
  • Between 2025 and 2030, Japan is expected to see increased investment in phlebotomy automation and integrated collection systems, positioning the country as a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2025-2030) 9.5% CAGR
  • Market Size, 2025 ~USD 272 Million
  • Forecast, 2030 ~USD 428.8 Million
  • Country Japan

Japan Blood Collection Devices Market Overview

Aging Population Driving Demand :

Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases diagnostic testing requirements and blood collection procedures, directly boosting market demand.

Advanced Healthcare Infrastructure :

Japan's world-class healthcare system and high adoption of advanced diagnostic technologies create a favorable environment for premium blood collection devices and innovative collection solutions.

Outpacing Global Growth :

Japan's 9.5% CAGR substantially exceeds the global average of 7.4%, indicating the country's market is expanding faster than worldwide trends due to unique demographic and healthcare factors.

Rising Chronic Disease Prevalence :

Increasing incidence of chronic diseases such as diabetes and cardiovascular conditions in Japan necessitates frequent blood testing and monitoring, fueling sustained market expansion through 2030.

Japan Blood Collection Devices Market Dynamics

  • This growth trajectory is underpinned by Japan's aging population requiring increased diagnostic interventions, coupled with the nation's commitment to preventive healthcare and early disease detection.
  • The market benefits from strong healthcare spending and technological advancement in collection methodologies. Looking ahead, Japan's market will likely see increased adoption of safety-engineered devices, automation in collection centers, and integration with digital health platforms.
  • Healthcare providers and diagnostic laboratories are investing in modernized collection infrastructure to improve patient experience and operational efficiency.
  • The convergence of demographic pressures and technological innovation positions Japan as a high-growth market within the Asia-Pacific region..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Japan's blood collection devices market will grow from $272.0M (2025) to $428.8M (2030) at a 9.5% CAGR, outpacing global growth.
      • Japan's aging demographic and rising chronic disease prevalence drive increased diagnostic testing and blood collection demand.
      • Japan's strict regulatory environment and focus on safety-engineered devices support premium product adoption and market expansion.
      • Japan is positioned as a key growth market in Asia Pacific, with investments in automation and integrated collection systems accelerating through 2030.

      Blood Collection Devices Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment PLASMA/WHOLE BLOOD TUBES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment MANUAL BLOOD COLLECTION (Method)
      Market Size Base Year (Billions) ~USD 9.11 (2025)
      Revenue Forecast (Billions) ~USD 13.02 (2030)
      Segments Covered Product, Type, System Type, Method, Application, End User

      Japan Blood Collection Devices Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Blood Bags
      • Blood Collection Systems/ Monitors
      • Blood Collection Tubes
      • Lancets
      • Needle & Syringes

      By Type

      • Coagulation Tubes
      • Edta Tubes
      • Esr Tubes
      • Glucose Tubes
      • Heparin Tubes
      • Plasma/Whole Blood Tubes
      • Serum Tubes

      By System Type

      • Non-Vacuum Type
      • Vacuum Type

      By Method

      • Automated Blood Collection
      • Manual Blood Collection

      By Application

      • Diagnostic Applications
      • Therapeutic Applications

      By End User

      • Blood Banks
      • Diagnostic & Pathology Labs
      • Hospitals, Ambulatory Surgical Centers, And Nursing Homes
      • Other End Users

      JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BLOOD BANKS115123.1130.6139148.8160172.6186.87.4
      DIAGNOSTIC & PATHOLOGY LABS155168.2181195.4212.2231.3253.1277.99
      HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES370.4405.3439.6478.6523.8575.3634.2701.69.8
      OTHER END USERS42.244.947.450.253.557.261.466.16.9
      TOTAL682.6741.6798.6863.2938.31023.81121.21232.59.1

      Target Audience

      • Medical Device Manufacturers : Manufacturers need Japan-specific market data to develop localized product strategies, assess market entry viability, and identify growth opportunities in Asia's premium healthcare market.
      • Healthcare Facility Operators : Hospital networks and diagnostic laboratories require market insights to optimize procurement strategies, evaluate supplier performance, and plan capital investments in collection infrastructure.
      • Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in Japan need validated market sizing and growth projections to assess portfolio companies and identify acquisition targets in blood collection devices.
      • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients in Japan require authoritative market data to support strategic recommendations, competitive analysis, and market opportunity assessments.
      • Government & Policy Organizations : Healthcare policy makers and government agencies need market intelligence to inform healthcare infrastructure planning, procurement policies, and regulatory frameworks for medical devices in Japan.

      Key Companies in the Japan Blood Collection Devices Market

      CompanyHQOwnershipStrongest segments
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions,
      ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula),
      NOLATOSwedenPublic CompanyMedical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC),
      QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables),
      GRIFOLS, S.A.SpainPublic CompanyBiopharma (plasma-derived medicines),Diagnostic,Bio Supplies,
      NIPRO CORPORATIONJapanPublic CompanyRenal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components),
      HAEMONETICS CORPORATIONUnited StatesPublic CompanyPlasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware,
      CARDINAL HEALTHUnited StatesPublic CompanyBranded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands),
      RETRACTABLE TECHNOLOGIES, INC.United StatesPublic CompanyVanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps,
      AB MEDICAL CO., LTD.IrelandPublic CompanyCardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio,

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ABBOTT LABORATORIES

      Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.

      NOLATO

      Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.

      QIAGEN NV

      QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.

      GRIFOLS, S.A.

      Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.

      NIPRO CORPORATION

      Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.

      HAEMONETICS CORPORATION

      Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.

      ICU MEDICAL, INC.

      ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.

      CARDINAL HEALTH

      Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.

      RETRACTABLE TECHNOLOGIES, INC.

      Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.

      AB MEDICAL CO., LTD.

      AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation ($272.0M in 2025) and verified growth projections through 2030, enabling accurate financial forecasting and investment decision-making specific to Japan's healthcare sector.
      • Competitive Positioning Intelligence : Understand Japan's market dynamics relative to global trends (9.5% vs. 7.4% CAGR), identifying competitive advantages and market entry opportunities in a faster-growing regional market.
      • Demographic-Driven Insights : Access analysis of Japan's aging population impact on blood collection demand, enabling targeted product development and marketing strategies aligned with the country's unique healthcare needs.
      • Strategic Expansion Planning : Leverage Japan-specific market data to evaluate expansion feasibility, resource allocation, and partnership opportunities within Asia-Pacific's most developed healthcare economy.
      • Regulatory & Infrastructure Context : Gain insights into Japan's advanced healthcare infrastructure and regulatory environment, essential for understanding market entry barriers, compliance requirements, and technology adoption rates.

      Frequently asked questions

      What is the current size of Japan's blood collection devices market?

      Japan's blood collection devices market is valued at $272.0 million in 2025 and is projected to reach $428.8 million by 2030.

      What is the expected growth rate for Japan's blood collection devices market?

      Japan's blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2030.

      What factors are driving growth in Japan's blood collection devices market?

      Key growth drivers in Japan include an aging population, increased prevalence of chronic diseases, rising diagnostic testing demand, and strict regulatory standards promoting safety-engineered devices.

      How does Japan's market growth compare to global trends?

      Japan's 9.5% CAGR outpaces the global blood collection devices market CAGR of 7.4%, reflecting stronger regional demand and healthcare investment.

      What innovations are expected in Japan's blood collection devices market by 2030?

      Japan is expected to see increased adoption of phlebotomy automation, integrated collection systems, and advanced safety-engineered devices that minimize needlestick injuries and improve infection control.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Blood Collection Devices Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Blood Collection Devices Market

      Data Triangulation

      The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.

      Stakeholders

      • Healthcare Service Providers (Hospitals and Pathology Centers)
      • Blood Collection Product Manufacturers
      • Blood Banks
      • Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
      • To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
      • To profile the key players in the market and comprehensively analyze their market positions and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market

       

      Get the Full Blood Collection Devices Market Report

      Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status